Paraneoplastic Endocrine Syndromes
"Paraneoplastic Endocrine Syndromes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Syndromes resulting from inappropriate production of HORMONES or hormone-like materials by NEOPLASMS in non-endocrine tissues or not by the usual ENDOCRINE GLANDS. Such hormone outputs are called ectopic hormone (HORMONES, ECTOPIC) secretion.
| Descriptor ID |
D009384
|
| MeSH Number(s) |
C04.588.322.490 C04.730.713 C19.344.473
|
| Concept/Terms |
Paraneoplastic Endocrine Syndromes- Paraneoplastic Endocrine Syndromes
- Endocrine Syndrome, Paraneoplastic
- Paraneoplastic Endocrine Syndrome
- Syndrome, Paraneoplastic Endocrine
- Syndromes, Paraneoplastic Endocrine
- Ectopic Hormone Syndromes
- Ectopic Hormone Syndrome
- Syndrome, Ectopic Hormone
- Syndromes, Ectopic Hormone
|
Below are MeSH descriptors whose meaning is more general than "Paraneoplastic Endocrine Syndromes".
Below are MeSH descriptors whose meaning is more specific than "Paraneoplastic Endocrine Syndromes".
This graph shows the total number of publications written about "Paraneoplastic Endocrine Syndromes" by people in this website by year, and whether "Paraneoplastic Endocrine Syndromes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Paraneoplastic Endocrine Syndromes" by people in Profiles.
-
No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours. Clin Endocrinol (Oxf). 2013 Apr; 78(4):533-8.
-
Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies. Endocr Pract. 2004 Mar-Apr; 10(2):125-8.
-
Endocrine paraneoplastic syndromes in lung cancer. Curr Opin Pulm Med. 2003 Jul; 9(4):313-20.
-
Paraneoplastic syndromes associated with bronchogenic carcinoma. Clin Chest Med. 2002 Mar; 23(1):257-64.
-
Effects of elevated serum insulinlike growth factor-II on growth hormone and insulinlike growth factor-I mRNA and secretion. Metabolism. 1989 Jan; 38(1):57-62.